Table 5.
Impact of HMGA2 expression pattern on survival of PDAC patient
Staining parameter | Total number of patients | Number of deceased patients | Median survival ± SD (95% CI) in months | p-value |
---|---|---|---|---|
Intensity cytoplasm | ||||
Negative | 11 | 9 | 15 ± 8.268 (0.000–31.205) | |
Weakly to strongly positive | 86 | 69 | 15 ± 1.558 (11.946–18.054) | 0.395 |
Number of cells with positively stained cytoplasm | ||||
≤ 80% | 41 | 35 | 15 ± 2.403 (10.291–19.709) | |
> 80% | 56 | 43 | 15 ± 3.453 (8.233–21.767) | 0.687 |
Sum score cytoplasm | ||||
≤ 4 | 41 | 35 | 15 ± 2.403 (10.291–19.709) | |
> 4 | 56 | 43 | 15 ± 3.453 (8.233–21.767) | 0.687 |
Staining intensity nuclei | ||||
Negative to weakly positive | 72 | 55 | 16 ± 1.952 (12.174–19.826) | |
Moderately to strongly positive | 25 | 23 | 8 ± 2.359 (3.375–12.625) | 0.045 |
Number of cells with positively stained nucleus | ||||
≤ 80% | 47 | 39 | 15 ± 1.217 (12.614–17.386) | |
> 80% | 50 | 39 | 17 ± 6.635 (5.956–28.044) | 0.591 |
Sum score nuclei | ||||
≤ 4 | 28 | 22 | 19 ± 2.531 (14.039–23.961) | |
> 4 | 69 | 56 | 15 ± 1.892 (11.293–18.707) | 0.230 |
p-values were estimated by log-rank-test with p ≤ 0.05 considered as significant and represented in bold numbers
SD standard deviation, CI confidence interval